Associate Professor
Clínica Alemana Universidad del Desarrollo, Chile
Mario I. Fernández, MD, is an Associate Professor at the Faculty of Medicine, Clínica Alemana Universidad del Desarrollo, in Santiago (Chile) in the Center of Genetics and Genomics, where he leads research projects in urothelial bladder cancer. He is also a Faculty in the Department of Urology at Clínica Alemana de Santiago, where his clinical practice (special interest in Urologic Oncology and Endourology) is located.
Dr. Fernández earned his undergraduate degree in Medicine from the P. Universidad Católica in Santiago and completed urology residency at Universidad de Chile. He then obtained his doctoral degree at the Department of Urology of the University Hospital Mannheim in Germany. After a one-year stay as Visiting Scientist at the Department of Urology of The University of Texas MD Anderson Cancer Center, he is a now a surgeon-scientist whose research efforts focus on genetic susceptibility, epidemiology, carcinogenesis, and clinical and molecular prognostic factors in urothelial tumors. He has authored over 80 publications in peer reviewed journals as well as book chapters and serves as a reviewer for over 20 journals.
Member of Sociedad Chilena de Urología, Editor-In-Chief of Revista Chilena de Urología and Head of the Bladder Cancer Working Group of CAU (Latin American Urological Confederation). Editorial Board Member in Bladder Cancer and JU Open Plus; also serving as reviewer for >20 journals. Member of the IBCG Core Committee and Scientific Advisory Board World Bladder Cancer Patient Coalition
Disclosure information not submitted.
Instructional Course: High-Quality TURBT - Practical Strategies to Improve Outcomes
Thursday, November 12, 2026
11:15 - 12:45 CET
Thursday, November 12, 2026
11:15 - 11:20 CET
Mandatory Detrusor Muscle Sampling In Every Patient?
Thursday, November 12, 2026
11:40 - 11:45 CET
Immediate Intravesical Therapy: Patient Selection
Thursday, November 12, 2026
12:20 - 12:25 CET
Thursday, November 12, 2026
12:25 - 12:45 CET
Hot Topic: Bladder Cancer: New Agents in the Setting of Unequal Access Across the World
Thursday, November 12, 2026
14:00 - 15:30 CET
What Is the Real Need for New Agents If BCG Treatment Is Adequate?
Thursday, November 12, 2026
14:30 - 14:38 CET